Possible connect to brain irritation may clarify the association among MS and exhaustion Kumar Jeetendra | August 27, 2020 As much as 60 percent of individuals with multiple sclerosis (MS) report that fatigue is that the disease’s most distressing symptom. And fatigue remains among MS’s puzzles — despite its incidence and significance, the root cause of this symptom remains unclear. In a study published in Neurology Neuroimmunology & Neuroinflammation, investigators from Brigham and Women’s …
Immunomodulatory drugs improve the achievement pace of cancer therapy Kumar Jeetendra | February 15, 2021 Immunomodulatory drugs, for example, Contergan derivatives lenalidomide and pomalidomide, have significantly improved the treatment of hematologic malignancies such as multiple myeloma. Researchers at the Technical University of Munich (TUM) have now further decoded the mode of action within this class of drugs. At exactly the exact same time, they identified new revolutionary targeted cancer therapies. …
New radiopharmaceutical shows therapeutic efficacy in preclinical model of ovarian disease Kumar Jeetendra | June 12, 2021 Preclinical trials of a new radiopharmaceutical to treat ovarian cancer have produced effective results, dramatically restricting tumor growth and diminishing tumor mass. Designed especially for ovarian cancers that are resistant to conventional therapies, the new radiopharmaceutical could be produced in 25 minutes at reduced cost, which contributes to better efficiency compared with alternative procedures. This …
